Nobel Innovations Made by Doctors at The Ground Level
Our primary business focus since inception in 2014 has been the development of an increasing number of patents on local anesthetics and periodontal methods and systems from the USPTO, fortifying numerous innovations across numerous niche markets including periodontal, local anesthesia drug, nanoparticles drug formulation, and periodontal Ai software development for diagnoses and planning for a digital customer treatment journey.
Our company's intellectual property derives its value from its high barriers to entry, specialized knowledge in know-how nanoparticles formulation technology, its utility comparison, global growth market opportunity, legal patent protection, and new and upcoming anticancer nanoparticles formulation technology.
First-of-its-kind Periodontal Software
We can’t ignore the fact that across the globe, periodontitis is the single most prevalent chronic infectious disease.
Our novel and revolutionary periodontal method and system are expected to reshape nearly every aspect of periodontal diagnoses and treatment with the potential to significantly impact the global market.
Nanoparticle Formulation Technology
Prefilled & Disposable Medical Device Solutions
Our primary business focus is the development of products for niche markets where there remains a significant unmet dental and medical need while few of our candidate products focus on novel indications and unprecedented labeling claims to differentiate our products from competitors.
We have developed substantially all of our resources since we began operation in 2012 to research and development in periodontal, anesthetics, nanoparticle formulation drugs, and prefilled medical device products.
We Take Pride in Our Numbers & Technology
Years of Experience
Class I Medical Device FDA Clearance as a stand alone device
Our latest growth
We understand FDA legislative issues, but more importantly, we keep up to date on various policy
With our finished and candidate product's comprehensive regulatory strategies in hand, we fully understand the expectations, carefully evaluate potential hurdles, and create master plans to proactively address them early in development.
Our master plan informs the entire development program. For example, elements from the regulatory strategic documents drive the medical device and drug plans, identifying issues that affect both design requirements and the associated budget.
Having a good understanding of the clinical, and technical development requirements—as well as timelines, achievable commercial claims, risks, and regulatory mechanisms to enhance product value and accelerated approval pathways are extremely helpful in designing an efficient early development pathway, assessing the value of the product, and knowing how far our company can proceed before needing additional financing or a partner.